Repligen is projected to grow revenue at 25% in 2020 and 17.3% in 2021 which means Repligen revenues are forecast to grow faster than I consider Repligen a buy, especially any time the stock
Repligen’s stock exploded on Friday April 26, 2019 as it increased $11.65 (up 20%) to $68.89. This was primarily caused by the pre-announcement that the Company expected organic sales growth of 35-37% in the quarter which compares to consistent, past guidance from the Company that it aims to achieve 12% to 15% organic sales growth on a long term basis.
On average, analysts forecast that RGEN's EPS will be $1.91 for 2021, with the lowest EPS forecast at $1.87, and the highest EPS forecast at $1.94. About the Repligen Corp. stock forecast As of 2021 March 25, Thursday current price of RGEN stock is 207.290$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception). Find the latest Repligen Corporation (RGEN) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Real time Repligen (RGEN) stock price quote, stock graph, news & analysis. About the Repligen Corp. stock forecast As of 2021 March 25, Thursday current price of RGEN stock is 207.290$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).
Repligen annual revenue for 2020 was $0.366B, a 35.53% increase from 2019. Repligen annual revenue for 2019 was $0.27B, a 39.28% increase from 2018. Repligen annual revenue for 2018 was $0.194B, a 37.38% increase from 2017. Stock split history for Repligen since 1990.
Find the latest Repligen Corporation (RGEN) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Real time Repligen (RGEN) stock price quote, stock graph, news & analysis. About the Repligen Corp. stock forecast As of 2021 March 25, Thursday current price of RGEN stock is 207.290$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).
Repligen Corp. quote is equal to 206.100 USD at 2021-04-11. Based on our forecasts, a long-term increase is expected, the "RGEN" stock price prognosis for 2026-04-03 is 482.749 USD. With a 5-year investment, the revenue is expected to be around +134.23%. Your current $100 investment may be up to $234.23 in 2026.
's earnings in 2021 is $59,926,000.. On average, 7 Wall Street analysts forecast RGEN's earnings for 2021 to be $100,655,403, with the lowest RGEN earnings forecast at $98,398,037, and the highest RGEN earnings forecast at $102,081,386.
on missed opportunities and non-performing styles in season. Secure optimal range planning through analysis. Analyze and forecast performance, stock and
2 days ago Proposed A RTeSYN a cquisition adds gold standard single - use downstream bioprocessing s ystems Advances Repligen’s S ystems strategy in Filtration and Chromatography , c omplement ing TangenX ® F lat S heet cassettes and OPUS ® PP C Completes acquisition of Non-Metallic Solutions (NMS), complementing our recent acquisition of EMT and further strengthens our single-use flow paths, … Repligen’s stock exploded on Friday April 26, 2019 as it increased $11.65 (up 20%) to $68.89.
Breaking News.
Beräkna reglar tak
07:02 AM ET. Repligen agrees to buy Spectrum in a cash-and-stock deal valued at $359 mln MarketWatch. 06:59 AM ET. Repligen's stock halted for news pending Investing in stocks, such as Repligen, is an excellent way to grow wealth. For long-term investors, stocks are a good investment even during periods of the market volatility - a stock market downturn means that many stocks are on sale. Repligen market cap is $10.4 b, and annual revenue was $270.25 m in FY 2019. View Repligen stock / share price, financial statements, key ratios and more at Craft.
2 days ago
Proposed A RTeSYN a cquisition adds gold standard single - use downstream bioprocessing s ystems Advances Repligen’s S ystems strategy in Filtration and Chromatography , c omplement ing TangenX ® F lat S heet cassettes and OPUS ® PP C Completes acquisition of Non-Metallic Solutions (NMS), complementing our recent acquisition of EMT and further strengthens our single-use flow paths, …
Repligen’s stock exploded on Friday April 26, 2019 as it increased $11.65 (up 20%) to $68.89. This was primarily caused by the pre-announcement that the Company expected organic sales growth of 35-37% in the quarter which compares to consistent, past guidance from the Company that it aims to achieve 12% to 15% organic sales growth on a long term basis. Repligen Corp stock news This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash. By directing …
Repligen Corporation (NASDAQ:RGEN) Q1 2020 Earnings Conference Call May 6, 2020, 08:30 AM ET Company Participants Sondra Newman - Senior Director, IR Tony Hunt - CEO & President Jon
Repligen Corporation Manufacturing facility.
K olbermann
Repligen stock jumped as much as 12% at one point Thursday, touching a record high of 155.27. On the stock market today , Repligen stock ended the session up 9% to 151.25. Repligen Stock Breaks
Repligen introduces novel affinity resin for the purification of the SARS CoV-2 Spike Protein for vaccine development and manufacturing.
Repligen (RGEN) stock price prediction is 295.17651 USD. The Repligen stock forecast is 295.17651 USD for 2022 March 25, Friday; and 792.064 USD for 2026 March 25, Wednesday with technical analysis.
Get the latest Repligen Corporation RGEN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. AC Investment Inc. delivers machine learning based share price forecast. How has Repligen's share price performed over time and what events caused price changes?
Analyze and forecast performance, stock and identify risks. Take actions on missed opportunities and on missed opportunities and non-performing styles in season. Secure optimal range planning through analysis.